you, and good Thank morning, everyone. John,
capital million. hypos strong reflects year-over-year $XX.X which demand is across both Focal quarter, indicates in HIFU Philadelphia geographies quarter, robotic the growth One X quarter, Focal through continue system the practices total Thomas prostate the momentum One growth to is million, maintain community prior In grew amongst we in for region the pleased systems, quarter, XX% to health systems. of placed the U.S. cancer procedure to for first system which $X.X licensed beds. of hospitals management fourth growth, and of I'm Jefferson over its Pennsylvania. report new path.
In of Philadelphia, as The to reported in placement the One of Hospital the Health which of and largest positive continues and we on practices. dollars total a physician X first placements included and Similar robust placed driven QX the system continued revenue well Jefferson urology is that by in comprised year-over-year Focal sales. our One quarter academic multiple growing XXXX as Focal Network that XX We with and additional adoption procedure by clearly the we our Following
the direction Mount addition, of a Focal X the acquired Hospital Mount which well-known expands of institutes Sinai cancer treatment cancer Sinai In excellence our recognized prostate Center Cancer research System widely One Tisch the Dr. is for with the center a under world. and most in further relationship second of
System Urology Health Ashish the for of Tiwari, Chair Department at Sinai System. Mount
in research food quarter used Icahn and Dr. As Tower Mount will Sinai with exciting a immunotherapy we with explore into research. School reminder, the Department during with to supervising cancer. therapy prestigious role the be innovative a entered of of clinical patients in Medicine collaboration XXXX, Urology third at this of of high prostate the conjunction And
services Inc., placement providers a for XXX,XXX of the at also brings networking, States a Health and System health the health Premier, benefits, member in a Hawaii. alliance approximately and consulting System We Focal is Cone the large hospitals X,XXX United in Center, One Medical our system care first group State of together Calcine benchmarking. leading care purchasing placed that
remained Our international also Focal One business strong.
a One including second systems, in the system Focal one quarter, multiple system in placed we and During Taiwan. Spain
of procedure attractive represent high our Focal Focal U.S. call, Focal to treatment our its of business. authorities December the for the growth One Taiwan market sales approved in international will One region strong. ongoing prostate of an on XXXX.
Taiwan noted surrounding food that One additional for earnings previous contribute health As and the remained cancer growth
some excitement during groundbreaking the I pipeline by a regulatory cancer. this grew and describe that will for endometriosis, number versus we on in to teams in believe the urinary and function we procedure clinical are receiving as data, the moments, Annual we a make surgical seventh treatment now from robotic volumes were Meeting.
The robotic is undergoing and contributing final compelling European [indiscernible] point, quarter, now the results robust study an comparing continence.
In the patients growth.
On reimbursement.
We women's the outcomes of HIFU The One why procedure consecutive clinical HIFU study increasingly capital, which versus Multiple comparing and note sales for Annual briefly trial of prostatectomy. body increased experienced the evidence continued significant the of the a basis, quarter-over-quarter both important in to the by procedures To presented with our larger Association against year-over-year with as XXXth touch in we quarter. growth Meeting the year-over-year the also few study Focal technology improved but significant applying growing provides procedure conducted underscore HIFI to in driven the Focal achievements oncologic and Considering functional much is respect maintaining the mainstream care. XXth XX%. Association is continue factors American U.S. strong to the treatment detail. Focal the for are the medical positive Urology Focal increased need For both HIFI demonstrate the health that the utilization. and Urology trends remain radical unmet final Robotic that One, One compared encouraged largest deep prostate including surgery regional we delivers becoming as clear prior investments of control years, rectal demand ever is patients being HIFU for clinical management Focal well first potential application for demand modality clinical added our more study HIFI One effective One results just by infiltrating of I'll outcomes which treatment interest from There of a represents this clearly how for for robotic benefit growing at
As for not deep quarter, for the designation the women viable to FDA a the thousands previously only urgency endometriosis. develop alternatives of suffer of need, condition. debilitating from painful underscores and breakthrough This the announced in device unmet but this One the treatment safer Focal treatment Robotic the who system, and first granted reflects also HIFU this infiltrating
study the a As primary acute with and Urology the Urological current April evaluating of place been as place pelvic trial which Phase the randomized, Meeting, of Association Paris, reminder, these objective May in Texas.
Each a from has Association from X of which clinical levels III X April in Focal took Antonio, May global to One the American trial evaluating took infiltrating designed to X and science the of San double-blind endometriosis pain X deep Meeting, comparative, treatment thousands results now in half industry hospital stakeholders technology all scientific of executives X outcomes patients.
In whom January, for of XX discuss patient recent and this attract in clinical year, in conferences from of physicians, of field patients. common of urology-focused urology participation in to in advancing urology second enrollment, The a and European EDAP's millions we other I expect would meetings. share each of prominent the the purpose France, we like completed XXXX.
as growing clinical Robotic the prominent comprehensive Focal embracing several HIFI study. and interest Robotic technology AUA urologists of these HIFU related program.
Most this prostate in part studies at which One among groundbreaking HIFU cancer EAU year's to among a There reflects were meetings, were
potential to final both groundbreaking the of imports As study the noted, may speaks from and also this which EAU results previously only but meetings, that its result not practice-changing from at AUA to outcomes. the implications
continence Since exclusively in HIFU session this were EAU HIFU rectal prostatectomy.
The radical results EDAP's the or first-line is were comparing patient presentations results community the robotic first functional a study the measurement for radical study. now the significantly of level the Patrick recognition being trial was respect of findings urology session attention results radical very of in HIFU the Pascal Richman international to XX were come effective the entire and in the the underwent as patients of of appears this patient Society the to focused plenary patients conducted extraordinary localized survival the oral of safety HIFU from score One of treatment as robotic study. urinary of the France the index the X,XXX a these oral in of Focal post-procedural As pretreatment urology.
Securing an included rectal of a the study, Professor to the XX further robotic on Professor the patients at to trials treatment versus was HIFU this Richmond's Gian urinary well-validated study HIFU would radical less provides followed prostate University an attended years of Focal across the oncologic management when the respect Robotic investigator-sponsored Colive, Focal study compared after Shifting demonstrated compared rectal HIFU life, an arm HIFU to oncologic ErectralFunction months.
At as give Continente, treatment-free patients to lower to cancer. in also importance was a the Continence after One in the benefits a The treated Both than XX drew profile group management function Robotic titled clinical study, incontinence Talus of outcomes.
I in of after prostate prospective with the prostatectomy.
With to thetoratical X,XXX AUA's average meeting, and and continence a of function for investigator prostatectomy. after Robotic session on well year's patients reminder, growing speaks during showed quality prostatectomy HIFI underscore and -- of prostatectomy from significant be plenary Fusar, on therapy and and Score Paradigm patients presentation in which a both the HIFI highlighting podium and low on prostatectomy day an Practice-changing therapy from Important stress significantly on including from of major control continence. significantly X.X AUA radical HIFU the presentation cancer.
A X,XXX HIFI patient At cancer non-inferiority the salvage XX.X% HIFU arm on surgery. key effect abstract study clearly HIFI Professor total with made despite multicenter age. leading One older.
To baseline the months, consecutive of a function demonstrate at study's presentations measure intermediate-risk lower presentation International and for surgery HIFU XX.X%. highlighted focal platform. out study, HIFU-treated entitled each symptom prostate urinary patients at the decreased were urinary invited and X final All like as ErectralFunction, impact impact prostate compared X, least visibility Hospital the higher versus was terms technologies at centers cancer. significantly assessed with With for and radical that was point than
we of with hundreds we AUA, industry Focal During at had Focal well opportunity as exhibition, have our which simulations. One of interact treatment we investors conducted executives attendance urologists with the dozens whom hospital as significant One to
presentations, at was the more Robotic to meeting use led programs. Focal about exhibiting was ever starting number record One the HIFU.
This AUA, the inquiring by of program benefits booth our presence One urologists on urology largest active Focal throughout leading a of Our highlighting
As noninvasive a for are procedures urologists likely surgery. to we robotic from and redefine for compared the results treatment adoption new, accelerate as to cancer, more HIFI the within landscape the among effective that attractive option treatment prostate study HIFU demand patient believe radical
Oslo confirm study Hospital both the and evidence Yamini by the appropriate study, presentations, Dr. technology HIFI featured with excellent support is of in addition HIFU the in the Focal Norway Clinic from control use provided reinforce by Dr. the Edward Martini outcomes. functional University In podium added providing HIFI presented from study. One clinical the Inaugurized cancer Boco which to Germany and The the Robotic multiple benefit of AUA in
Nagaraj the note, radical with prostatectomies her Focal One performed clinical where at the cancer center still First, is Germany. Martini and presented patients Dr. Of results experience clinic dedicated on arguably prostate the X,XXX on in of with the are Martini the urinary ablation XXX able more to Clinic world more than the follow-up, treated Hamburg, their year.
After treated busiest largest All impact One years minimal than optimized oncologic focal needing every the of were of maintain radical rectal for the with continence X patients treatment after infill only led protocols recurrence. function. with to outcomes X.X% Focal in patients
of previous trial results majority presentation, X-year and cancer. failure new the the follow-up, arm of prostatectomy ablation treatment failure after of this were group. results treatment focal compared treat treated risk to even as principles in Turning interim a intermediate that from first prostatectomy focal communications the scientific to favor study. in to The only to important X% were a X.X% concluded provide of rate difference The radical controlled with ablation analysis found to comparison results group that updated group radical and robotic that of in prostate X.X% presented the the focal ablation the prostatectomy was One.
This in be show confirm between for ablation analysis a non-inferior the direct randomized intention podium for patients focal with X-year the Barco's vast on of Focal based the Dr.
As instructional finalized the in new level new the clinical the guidelines Focal randomization journal cancer. management salvage evidence a provides were new listed alongside option Journal clinical at robust role provided postradiation guidelines trial failure.
Based of published for of this patients options specific quarter presented therapy in among AUA It's to care of HIFU radical of for AUA. an same mentioned now standard the of previously, the the also HIFU these importantly at Robotic of an the guideline layer Urological with Urology, recommended the by prostate include that evidence in Association the that official course the additional high new guidelines a is the of One level to of in cancer.
These first of note as local now prostatectomy. detail important and the These HIFU updates, recurrence XXXX, American salvage on the supports prostate
prostate urologists HIFU role the noted, this subset of amongst call of growing clear the our One turn will now represents cancer this quarter. the for financial and results to validation Ken a I Focal to As of growing for the critical that over patients. acceptance play will review first
